True Green Bio Energy Q2 Profit Jumps to Rs 18.02 Crore

ENERGY
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
True Green Bio Energy Q2 Profit Jumps to Rs 18.02 Crore

True Green Bio Energy Ltd reported a massive jump in its standalone financials for Q2 FY27. Quarterly revenue soared to Rs 234.55 crore from Rs 2.20 crore last year, with net profit rising to Rs 18.02 crore. Investors are watching for the sustainability of this high-growth trajectory.

True Green Bio Energy Reports Massive Q2 Profit Jump

Revenue from operations reached Rs 234.55 crore for the quarter ended September 30, 2026.
Net profit for the same period stood at Rs 18.02 crore, up from Rs 0.86 crore last year.

Reader Takeaway: Exceptional year-over-year revenue growth reflects massive operational scaling, though long-term margin sustainability remains the key monitorable for investors.

What just happened

True Green Bio Energy Ltd has released its standalone unaudited financial results for the quarter and half-year ended September 30, 2026. The board meeting, held on November 3, 2026, confirmed a significant expansion in the company's operational footprint compared to the previous fiscal year.

Why this matters

The company saw a dramatic shift in its top-line performance, with revenue jumping from Rs 2.20 crore in the year-ago period to Rs 234.55 crore in Q2 FY27. This surge indicates a rapid change in business scale, which has directly translated into a healthier bottom line, with quarterly net profit rising to Rs 18.02 crore from Rs 0.86 crore in Q2 FY26.

What changes now

The company’s balance sheet also shows strengthening, with total assets rising to Rs 597.88 crore as of September 30, 2026, up from Rs 557.74 crore at the end of March 2026. Total equity has similarly increased to Rs 198.80 crore, reflecting a more robust capital structure.

What to track next

Investors should look for management commentary on the sustainability of this exponential growth. Maintaining these elevated revenue levels and operational margins in the coming quarters will be critical to validating the current valuation.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.